Use of antibiotics in children: A danish nationwide drug utilization study

Journal of Pediatric Infectious Diseases

Volumn 34, Issue 2, 2015, Pages e16-e22

  Pottegård, Anton ^a,b   Broe, Anne ^a   Aabenhus, Rune ^c   Bjerrum, Lars ^c   Hallas, Jesper ^a,b   Damkier, Per ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antibiotics; Children; Pharmacodepidemiology; Prescribing

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; PENICILLIN V; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN DERIVATIVE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CHILD; DENMARK; DRUG USE; DRUG UTILIZATION; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEX RATIO; HEALTH CARE POLICY; NEWBORN; STANDARDS; TRENDS;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DENMARK; DRUG UTILIZATION; FEMALE; HEALTH POLICY; HUMANS; INFANT; INFANT, NEWBORN; MALE;

EID: 84925381936     PISSN: 13057707     EISSN: 13057693     Source Type: Journal    
DOI: 10.1097/INF.0000000000000519     Document Type: Article

References (47)

1. Clavenna A, Bonati M. Drug prescriptions to outpatient children: a review of the literature. Eur J Clin Pharmacol. 2009;65:749-755.
2. Smith R, Coast J. The true cost of antimicrobial resistance. BMJ. 2013;346:f1493.
3. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-587.
4. Seppälä H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997;337:441-446.
5. World Health Organization. Draft Global action plan on antimicrobial resistance. Available at: www.who.int. Accessed August 7, 2014.
6. World Health Organization. Antimicrobial resistance. 67.25 WHO resolution on AMR . Available at: www.who.int. Accessed August 7, 2014.
7. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis Off Publ Infect Dis Soc Am. 2009;48:1-12.
8. Tan T, Little P, Stokes T; Guideline Development Group. Antibiotic prescribing for self limiting respiratory tract infections in primary care: summary of NICE guidance. BMJ. 2008;337:a437.
9. Van Gageldonk-Lafeber AB, Heijnen M-LA, Bartelds AIM, Peters MF, van der Plas SM, Wilbrink B. A case-control study of acute respiratory tract infection in general practice patients in The Netherlands. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;41:490-497.
10. Venekamp RP, Sanders S, Glasziou PP, Del Mar CB, Rovers MM. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2013;1:CD000219.
11. Thrane N, Steffensen FH, Mortensen JT, Schønheyder HC, Sørensen HT. A population-based study of antibiotic prescriptions for Danish children. Pediatr Infect Dis J. 1999;18:333-337.
12. Clavenna A, Bonati M. Differences in antibiotic prescribing in paediatric outpatients. Arch Dis Child. 2011;96:590-595.
13. Matthys J, De Meyere M, van Driel ML, De Sutter A. Differences among international pharyngitis guidelines: not just academic. Ann Fam Med. 2007;5:436-443.
14. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(suppl 7):38-41.
15. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment 2013. Oslo, Norway: 2012.
16. Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39(suppl 7):22-25.
17. European Medicines Agency (EMA). ICH Topic E 11 - Clinical Investigation of Medicinal Products in the Paediatric Population. Note for guidance on clinical investigation of medicinal products in the paediatric population (CPMP/ICH/2711/99). 2001.
18. Hallas J, Støvring H. Templates for analysis of individual-level prescription data. Basic Clin Pharmacol Toxicol. 2006;98:260-265.
19. Paulsen MS, Andersen M, Thomsen JL, et al. Multimorbidity and blood pressure control in 37 651 hypertensive patients from Danish general practice. J Am Heart Assoc. 2013;2:e004531.
20. Schroll H, Christensen RD, Thomsen JL, Andersen M, Friborg S, Søndergaard J. The Danish model for improvement of diabetes care in general practice: impact of automated collection and feedback of patient data. Int J Fam Med. 2012;2012:208123.
21. Marra F, Monnet DL, Patrick DM, et al. A comparison of antibiotic use in children between Canada and Denmark. Ann Pharmacother. 2007;41:659-666.
22. Holstiege J, Garbe E. Systemic antibiotic use among children and adolescents in Germany: a population-based study. Eur J Pediatr. 2013;172:787-795.
23. Blix HS, Engeland A, Litleskare I, Rønning M. Age- and gender-specific antibacterial prescribing in Norway. J Antimicrob Chemother. 2007;59:971-976.
24. Högberg L, Oke T, Geli P, Lundborg CS, Cars O, Ekdahl K. Reduction in outpatient antibiotic sales for pre-school children: interrupted time series analysis of weekly antibiotic sales data in Sweden 1992-2002. J Antimicrob Chemother. 2005;56:208-215.
25. De Bont EGPM, van Loo IHM, Dukers-Muijrers NHTM, et al. Oral and topical antibiotic prescriptions for children in general practice. Arch Dis Child. 2013;98:228-231.
26. Dommergues MA, Hentgen V. Decreased paediatric antibiotic consumption in France between 2000 and 2010. Scand J Infect Dis. 2012;44:495-501.
27. Schneider-Lindner V, Quach C, Hanley JA, Suissa S. Secular trends of antibacterial prescribing in UK paediatric primary care. J Antimicrob Chemother. 2011;66:424-433.
28. Zhong W, Maradit-Kremers H, St. Sauver JL, et al. Age and sex patterns of drug prescribing in a defined American population. Mayo Clin Proc. 2013;88:697-707.
29. Miller GE, Hudson J. Children and antibiotics: analysis of reduced use, 1996-2001. Med Care. 2006;44(suppl 5):I36-I44.
30. Finkelstein JA, Stille C, Nordin J, et al. Reduction in antibiotic use among US children, 1996-2000. Pediatrics. 2003;112(3 pt 1):620-627.
31. Plasschaert AIO, Rovers MM, Schilder AGM, Verheij TJM, Hak E. Trends in doctor consultations, antibiotic prescription, and specialist referrals for otitis media in children: 1995-2003. Pediatrics. 2006;117:1879-1886.
32. Piovani D, Clavenna A, Bonati M; Interregional Italian Drug Utilisation Group. Drug use profile in outpatient children and adolescents in different Italian regions. BMC Pediatr. 2013;13:46.
33. Antibiotic Treatment Guidelines 2000-2012. Available at: http://pro.medicin.dk/Specielleemner/Emner/318019. Accessed April 12, 2014.
34. Danish Health and Medicines Authority. Information to physicians and other healtcare professionals. Introduction of a conjugated vaccine (PCV7) against pneumococci in the Danish Children vaccine Program. 2007. Available at: www.sst.dk and http://sundhedsstyrelsen.dk/~/media/ DF5A3CF3670344EF830248CECCB0DB11.ashx. Accessed April 12, 2014.
35. Statens Serum Institut [Vaccine coverage for conjugated pneumocci (PVC) vaccine at 12 months of age from 2007-2012]. Available at: www.ssi.dk. Accessed December 5, 2013.
36. Pottegård A, Hallas J. Children prefer bottled amoxicillin. Ugeskr Laeger. 2010;172:3468-3470.
37. Goossens H. Antibiotic consumption and link to resistance. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2009;15(suppl 3):12-15.
38. Bronzwaer SLAM, Cars O, Buchholz U, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis. 2002;8:278-282.
39. Fossum GH, Lindbæk M, Gjelstad S, Dalen I, Kværner KJ. Are children carrying the burden of broad-spectrum antibiotics in general practice? Prescription pattern for paediatric outpatients with respiratory tract infections in Norway. BMJ Open. 2013;3:pii: e002285.
40. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.
41. World Health Organization. The evolving threat of antimicrobial resistance - Options for action. World Health Organization 2012. Available at: www.who.int and http://whqlibdoc.who.int/publications/2012/9789241503181-eng.pdf?ua=1. Accessed April 12, 2012.
42. Högberg L, Ekdahl K, Sjöström K, et al. Penicillin-resistant pneumococci in Sweden 1997-2003: increased multiresistance despite stable prevalence and decreased antibiotic use. Microb Drug Resist Larchmt N. 2006; 12:16-22.
43. Centre for Clinical Practice at NICE (UK). Respiratory Tract Infections - Antibiotic Prescribing: Prescribing of Antibiotics for Self-Limiting Respiratory Tract Infections in Adults and Children in Primary Care. London, United Kingdom: National Institute for Health and Clinical Excellence (UK); 2008. Available at: http://www.ncbi.nlm.nih.gov/books/ NBK53632/. Accessed April 12, 2014.
44. Statens Serum Institut. Disease monitoring - Yearly reports 2004-2012. Available at: www.ssi.dk Accessed April 12, 2014.
45. Hinnerskov M, Therkildsen JM, Cordoba G, Bjerrum L. Macrolide overuse for treatment of respiratory tract infections in general practice. Dan Med Bull. 2011;58:A4356.
46. Bergman M, Huikko S, Pihlajamäki M, et al. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin Infect Dis Off Publ Infect Dis Soc Am. 2004;38:1251-1256.
47. Azithromycin Summary of Product Characteristics. Available at: www.produktresume.dk. Accessed April 12, 2014.